We are live on ! Find out more
CSM

CAMG Solamere Management Portfolio holdings

AUM $122M
1-Year Est. Return 33.76%
This Fund
S&P 500
This Quarter Est. Return
-1.25%
1 Year Est. Return
+33.76%
3 Year Est. Return
+51.71%
5 Year Est. Return
+95.67%
10 Year Est. Return
AUM
$220M
AUM Growth
-$5.23M
Cap. Flow
-$2.86M
Cap. Flow %
-1.3%
Top 10 Hldgs %
24.87%
Holding
146
New
11
Increased
46
Reduced
56
Closed
8

Sector Composition

Rank Sector Weight
1 Financials 17.56%
2 Technology 12.75%
3 Healthcare 8.87%
4 Energy 6.94%
5 Consumer Discretionary 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGG icon
76
iShares Core US Aggregate Bond ETF
AGG
$137B
$851K 0.39%
7,924
BMY icon
77
Bristol-Myers Squibb
BMY
$131B
$843K 0.38%
13,347
-2,108
-14% -$136K
SPGI icon
78
S&P Global
SPGI
$119B
$841K 0.38%
4,381
-226
-5% -$41.7K
GL icon
79
Globe Life
GL
$14.4B
$829K 0.38%
9,849
-193
-2% -$16.9K
BSV icon
80
Vanguard Short-Term Bond ETF
BSV
$44.6B
$812K 0.37%
10,360
BND icon
81
Vanguard Total Bond Market
BND
$157B
$765K 0.35%
9,541
TD icon
82
Toronto Dominion Bank
TD
$200B
$716K 0.33%
12,614
+166
+1% +$9.71K
EEM icon
83
iShares MSCI Emerging Markets ETF
EEM
$29.2B
$694K 0.32%
14,384
+407
+3% +$20K
FAST icon
84
Fastenal
FAST
$58.3B
$675K 0.31%
49,628
-488
-1% -$6.72K
VOE icon
85
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$674K 0.31%
+6,193
New +$696K
PG icon
86
Procter & Gamble
PG
$342B
$659K 0.3%
8,295
CVS icon
87
CVS Health
CVS
$123B
$647K 0.29%
10,465
-654
-6% -$46.9K
PSX icon
88
Phillips 66
PSX
$82B
$632K 0.29%
6,524
-914
-12% -$89K
NVS icon
89
Novartis
NVS
$293B
$614K 0.28%
8,539
+101
+1% +$7.69K
DUK icon
90
Duke Energy
DUK
$96.6B
$590K 0.27%
7,590
-504
-6% -$39K
SO icon
91
Southern Company
SO
$107B
$590K 0.27%
13,304
-1,718
-11% -$76.3K
RYN icon
92
Rayonier
RYN
$6.45B
$539K 0.25%
16,930
-1,288
-7% -$39.2K
GEN icon
93
Gen Digital
GEN
$16.8B
$537K 0.24%
20,805
-250
-1% -$6.8K
BNY
94
Bank of New York Mellon
BNY
$108B
$529K 0.24%
10,318
-250
-2% -$13.9K
BRK.B icon
95
Berkshire Hathaway Class B
BRK.B
$1.13T
$521K 0.24%
2,609
+60
+2% +$12.3K
RDS.A
96
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$514K 0.23%
8,122
-685
-8% -$45.1K
IJS icon
97
iShares S&P Small-Cap 600 Value ETF
IJS
$8.26B
$511K 0.23%
6,774
+1,508
+29% +$116K
ABBV icon
98
AbbVie
ABBV
$431B
$491K 0.22%
5,180
+119
+2% +$13.1K
BF.B icon
99
Brown-Forman Class B
BF.B
$13B
$455K 0.21%
8,434
+451
+6% +$21.4K
ORCL icon
100
Oracle
ORCL
$413B
$449K 0.2%
9,834
-1,697
-15% -$84.4K

Similar funds

CAMG Solamere Management's Q1 2018 Portfolio in Review

As of Q1 2018, CAMG Solamere Management held 146 positions worth $220M, down 2.3% from $225M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

CAMG Solamere Management's Q1 2018 filing shows 11 new, 46 increased, 56 reduced and 8 closed positions. Its largest new stake was GSK: 86,808 shares worth $4.24M. The largest sale was Lear, an estimated $3.94M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • CAMG Solamere Management's largest Q1 2018 buy was GSK: 86,808 shares worth $4.24M.
  • CAMG Solamere Management added most to AT&T in Q1 2018, an estimated $1.65M increase.
  • CAMG Solamere Management's biggest Q1 2018 reduction was iShares Intermediate Government/Credit Bond ETF, cutting an estimated $3.73M.
  • CAMG Solamere Management fully exited Lear in Q1 2018, selling an estimated $3.94M.
  • CAMG Solamere Management's ten largest holdings make up 25% of its $220M portfolio in Q1 2018.
  • CAMG Solamere Management opened 11 new positions and closed 8 in Q1 2018.
  • CAMG Solamere Management's portfolio value fell 2.3% quarter-over-quarter to $220M.

Based on CAMG Solamere Management's 13F filing for Q1 2018, filed 15 May 2018.